Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores 
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 
One of the deadliest diseases that continue to plague the world’s population is HIV/AIDS. A report reveals that scientists are now another step closer to developing a cure after tests on mice and monkeys proved to be successful.
A recent report reveals that researchers from Emory University in Atlanta, Georgia, and North Carolina University conducted tests on a drug named AZD5582 on lab monkeys that had HIV. The drug essentially forced the virus to react and then killed it, proving to be a success. As this method helped cure monkeys of HIV, then the results on humans would prove to be promising, once the human trials begin.
The researchers at Emory University conducted this study on 12 monkeys that were suffering from SIV, which is similar to HIV, and were treated with ART. The scientists then used the drug to force the virus out of hiding, and thus killed it when it appeared. The drug being used was practically safe; however, one monkey suffered a temporary fever and a loss of appetite.
As for the researchers at North Carolina University, they conducted the test using the same drug on mice that had human HIV cells and found it to be a success. All that is left for both groups of researchers is to combine their findings and start doing human trials for the potential HIV/AIDS cure. The best part of these studies is that despite using two different animals, the result turned out the same, and this breakthrough will, therefore, open up many possibilities in potential HIV/AIDS treatment. If the human trials also prove to be a success, then it will not be long before the disease is deemed curable for good.
In line with a breakthrough in HIV/AIDS treatment, three infectious disease experts have been assessing potential existing drugs that may help get rid of the virus. They did their assessment based on the criteria of why and where this cure would be needed and how they can make it happen. They noticed that most of the research being done towards HIV/AIDS was in places where the disease is not a leading ailment, and the number of cases would likely be much smaller. They then concluded that this should take into account the needs and economies of people who are in dire need of a cure.
